Somerset Indus Capital Partners has successfully closed its third fund, Fund III, at $288 million, surpassing its initial target of $250 million. The fund attracted a diverse set of global institutional investors, including development finance institutions, investment firms, insurance companies, and family offices from various regions.
Specializing in healthcare investments, Somerset aims to support scalable healthcare ventures that offer affordable and quality care in sectors like healthcare delivery, pharmaceuticals, and medical devices. Fund III will focus on bridging healthcare access disparities in India’s underserved markets.
Typically investing between $15 million and $40 million per company, Somerset’s co-investment approach allows participation in larger deals ranging from $60 to $80 million. The additional capital infusion will facilitate investments in transformative healthcare areas such as preventive care, insurance solutions, and innovative medical technologies.
Somerset’s previous funds have demonstrated strong performance, with Fund I achieving a 4.0x DPI and Fund II progressing towards exits. The firm has made successful investments in companies like Cyrix Healthcare and NU Hospitals, and is committed to driving impactful healthcare solutions beyond major cities in India.
Source: Entrackr : Latest Posts